Skip to content
Peptigraph home

SS-31 Side Effects: What Studies and Users Report

What FDA labels, clinical studies and people who use SS-31 report, how strong that evidence is, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureMitochondria-targeting peptideUpdated

Side effects reported in studies

Adverse reactions from the FDA label come first, then side effects reported in individual studies. Frequencies are quoted as the source gives them; animal results are labelled.

Side effects of SS-31 in labels and published studies
Side effectHow commonStudy typeSource
Any local administration reaction12 of 12 (100%) on elamipretide vs 8 of 12 (67%) on placeboFDA labelFDA label (Forzinity)
Injection site erythema12 of 12 (100%) vs 3 of 12 (25%) on placeboFDA labelFDA label (Forzinity)
Injection site pain9 of 12 (75%) vs 5 of 12 (42%) on placeboFDA labelFDA label (Forzinity)
Injection site induration8 of 12 (67%) vs 2 of 12 (17%) on placeboFDA labelFDA label (Forzinity)
Eosinophilia“Increases in absolute eosinophil counts were noted frequently in studies where duration of administration of FORZINITY was 30 days or greater.”Frequency not statedFDA labelFDA label (Forzinity)
Hypersensitivity reactions“Hypersensitivity reactions, including serious allergic reactions requiring emergency medical intervention, have been reported in patients receiving FORZINITY.”Frequency not statedFDA labelFDA label (Forzinity)
Injection site pruritus8 of 12 (67%) vs 2 of 12 (17%) on placeboFDA labelFDA label (Forzinity)
Injection site bruising3 of 12 (25%) vs none on placeboFDA labelFDA label (Forzinity)
Injection site urticaria3 of 12 (25%) vs none on placeboFDA labelFDA label (Forzinity)
Injection site hemorrhagenone on elamipretide vs 1 of 12 (8%) on placeboFDA labelFDA label (Forzinity)
Injection site reactions86% vs 71% placeboHuman RCTn = 176Ophthalmology science 2025, PMID 39605874
Injection site pruritus46 of 117 on elamipretide; 0 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Injection site pain33 of 117 on elamipretide; 6 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Injection site erythema22 of 117 on elamipretide; 0 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Injection site haemorrhage17 of 117 on elamipretide; 4 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Injection site induration16 of 117 on elamipretide; 3 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Injection site mass13 of 117 on elamipretide; 0 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Injection site swelling11 of 117 on elamipretide; 0 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Eosinophil count increased7 of 117 on elamipretide; 0 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Hypertension5 of 117 on elamipretide; 0 of 59 on placeboHuman RCTn = 176ClinicalTrials.gov NCT03891875
Injection site erythema94 of 109 on elamipretide (24-week double-blind period); 31 of 109 on placeboHuman RCTn = 218ClinicalTrials.gov NCT03323749
Injection site pruritus82 of 109 on elamipretide (24-week double-blind period); 10 of 109 on placeboHuman RCTn = 218ClinicalTrials.gov NCT03323749
Injection site pain43 of 109 on elamipretide (24-week double-blind period); 20 of 109 on placeboHuman RCTn = 218ClinicalTrials.gov NCT03323749
Injection site swelling42 of 109 on elamipretide (24-week double-blind period); 7 of 109 on placeboHuman RCTn = 218ClinicalTrials.gov NCT03323749
Injection site induration31 of 109 on elamipretide (24-week double-blind period); 6 of 109 on placeboHuman RCTn = 218ClinicalTrials.gov NCT03323749
Eosinophil count increased7 of 109 on elamipretide (24-week double-blind period); 0 of 109 on placeboHuman RCTn = 218ClinicalTrials.gov NCT03323749
Injection site reactions80%Human RCTn = 30Journal of cachexia, sarcopenia and muscle 2020, PMID 32096613
Injection site reactionsmost common events; all participants had 1 or more mild or moderate adverse eventsHuman uncontrolled trialn = 21Ophthalmology science 2022, PMID 36246187
Transient visual impairment1 participant withdrewHuman uncontrolled trialn = 21Ophthalmology science 2022, PMID 36246187
Intolerable injection site reaction1 participant exited the studyHuman uncontrolled trialn = 19Ophthalmology science 2022, PMID 36246181
Conversion to neovascular AMD1 participant exited the studyHuman uncontrolled trialn = 19Ophthalmology science 2022, PMID 36246181

Overall safety findings

What studies said about safety as a whole, without naming a specific effect.

Overall safety findings for SS-31 in published studies
FindingHow commonStudy typeSource
Most adverse events mild to moderatemostHuman RCTn = 218Neurology 2023, PMID 37268435
No serious adverse eventsnoneHuman RCTn = 36Circulation. Heart failure 2017, PMID 29217757
Injection-site reactionsmost commonHuman uncontrolled trialn = 10Genetics in medicine 2024, PMID 38602181

What users report

Anecdotal evidence, 0 of 4

Side effects people describe from their own use of SS-31, quoted from 28 Reddit threads we read in r/Peptides and r/Retatrutide (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.

Side effects people report from using SS-31
What people noticedPeople reporting itIn their words
Tiredness or lethargy8“have the most strange severe fatigue. Ive been falling asleep all the time” r/Peptides, Mar 2026“it makes me super tired when I take it” r/Peptides, Jul 2025
Dizziness2“I feel kind of dizzy” r/Peptides, Jul 2025“After taking I find myself getting dizzy when standing up too quick.” r/Peptides, Jun 2026
Restlessness or feeling wired2“that had me wired the entire day and I couldn't sleep at night” r/Peptides, Apr 2026“I feel a bit of restlessness” r/Peptides, Mar 2026
Trouble sleeping1“I couldn't sleep at night” r/Peptides, Apr 2026
Higher resting heart rate1“when I took SS-31 it greatly increased my resting heart rate” r/Peptides, Apr 2026
Headache1“gives me a mild headache post injection” r/Retatrutide, Mar 2025
Itching after injection1“it being itchy after I pin” r/Peptides, Mar 2026
Achy legs1“weird warm achey legs” r/Peptides, Mar 2026
Diarrhea1“I have had diarrhea like crazy” r/Peptides, Aug 2024Also taking other compounds
Coughing up mucus1“coughing up all kinds of disgustingness” r/Peptides, Aug 2024Also taking other compounds
Hives or severe allergic reaction1“Got hives all over the place.” r/Peptides, Feb 2026Also taking other compounds
Numbness or tingling1“my entire body got jittery and numb” r/Peptides, Feb 2026Also taking other compounds

A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.

What is not known

  • How common each effect is at the doses people use outside of studies.
  • Effects that take longer to appear than the length of the published studies.
  • How SS-31 interacts with other medicines and supplements.
  • Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.

When to get medical help

Get urgent care for: trouble breathing, swelling of the face or throat, a widespread rash, severe or lasting stomach pain, fainting, or an injection site that becomes hot, red and spreading.

This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.

What the Forzinity label warns about

The Forzinity label's contraindication is serious hypersensitivity to elamipretide or any of the excipients in Forzinity.[1]

The label says hypersensitivity has included rash and respiratory symptoms.[1]

The label also warns of benzyl alcohol toxicity and says not to use Forzinity in neonates.[1]

The most common adverse reactions are at the injection site.[1]

Injection-site reactions in the trials

In a crossover trial in adults with mitochondrial myopathy, injection site reactions were the most commonly reported adverse events (80%), most of them mild.[4]

In an age-related macular degeneration trial, adverse events were more common on elamipretide than placebo, mainly at the injection site.[2]

In the larger mitochondrial myopathy trial, most events were mild to moderate.[3]

An early randomized, placebo-controlled heart-failure trial of elamipretide reported no serious adverse events.[5]

Common questions

What are the side effects of SS-31?

The FDA label lists any local administration reaction, injection site erythema, injection site pain among others. The table on this page gives how often each happened and links each source.

What side effects do people who use SS-31 report?

In the 28 Reddit threads we read (11 Oct 2026), people most often described tiredness or lethargy (8 people), dizziness (2 people), restlessness or feeling wired (2 people). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.

Is SS-31 safe?

The Forzinity label lists a hypersensitivity contraindication and warns of benzyl alcohol toxicity, saying not to use it in neonates.[1]

What are the side effects of elamipretide?

Injection-site reactions are the most common, in both the label and long-term Barth syndrome follow-up.[6]

More on SS-31

Sources

  1. 1FORZINITY (ELAMIPRETIDE HYDROCHLORIDE) INJECTION [STEALTH BIOTHERAPEUTICS INC.]FDA label (Forzinity), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  2. 2ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation.Ophthalmology science · 2025PMID 39605874Accessed 2 Oct 2026
  3. 3Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.Neurology · 2023PMID 37268435Accessed 2 Oct 2026
  4. 4A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy.Journal of cachexia, sarcopenia and muscle · 2020PMID 32096613Accessed 2 Oct 2026
  5. 5Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.Circulation. Heart failure · 2017PMID 29217757Accessed 2 Oct 2026
  6. 6Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER.Genetics in medicine : official journal of the American College of Medical Genetics · 2024PMID 38602181Accessed 2 Oct 2026
  7. 7A Phase 2 Randomized, Double-Masked, Placebo-Controlled Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Elamipretide in Subjects With Age-Related Macular Degeneration With Non-central Geographic AtrophyClinicalTrials.gov (U.S. National Library of Medicine) · 2019clinicaltrials.govAccessed 11 Oct 2026
  8. 8A Phase 3 Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Daily Subcutaneous Injections of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Treatment ExtensionClinicalTrials.gov (U.S. National Library of Medicine) · 2017clinicaltrials.govAccessed 11 Oct 2026
  9. 9Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.Ophthalmology science · 2022PMID 36246187Accessed 11 Oct 2026
  10. 10Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.Ophthalmology science · 2022PMID 36246181Accessed 11 Oct 2026
  11. 11Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  12. 12Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  13. 13Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  14. 14Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  15. 15Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  16. 16Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
  17. 17Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
  18. 18Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
  19. 19Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026

Found an error? Report a correction.